readthroughSign in
CompanyAARDNasdaqSan Diego, CA

Aardvark Therapeutics, Inc.

Aardvark Therapeutics develops small-molecule therapeutics targeting hunger signaling for Prader-Willi Syndrome and metabolic diseases.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 13Latest story